says Eli C. Lewis, PhD. In a study, people with type 1 diabetes were given an Alpha1-Antitrypsin (AAT) infusion once a week for eight weeks. AAT is made from an anti-inflammatory blood protein.

Breakthrough:  Half of those who received AAT produced more of their own insulin for more than two years.  AAT is expected to be FDA approved for diabetes within two years. Until then, doctors can prescribe it “off label”.

Source: Eli C. Lewis, PhD. is director of the Clinical Islet Lab., Ben-Gurion University of the Negev, Beer-Sheva, Israel Bottom Line Personal  July 2014